Found: 29
Select item for more details and to access through your institution.
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 299, n. 3, p. 289
- By:
- Publication type:
- Article
Androgen Suppression Plus Radiation Therapy for Prostate Cancer—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 17, p. 2084, doi. 10.1001/jama.292.17.2085-a
- By:
- Publication type:
- Article
6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate Cancer: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 7, p. 821, doi. 10.1001/jama.292.7.821
- By:
- Publication type:
- Article
Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 10, p. e2336390, doi. 10.1001/jamanetworkopen.2023.36390
- By:
- Publication type:
- Article
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
MRI-Based Radiotherapy Planning to Reduce Rectal Dose in Excess of Tolerance.
- Published in:
- Prostate Cancer (20903111), 2022, p. 1, doi. 10.1155/2022/7930744
- By:
- Publication type:
- Article
Natural History of Untreated Prostate Specific Antigen Radio recurrent Prostate Cancer in Men with Favorable Prognostic Indicators.
- Published in:
- Prostate Cancer (20903111), 2014, p. 1, doi. 10.1155/2014/912943
- By:
- Publication type:
- Article
Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial.
- Published in:
- Prostate Cancer (20903111), 2014, p. 1, doi. 10.1155/2014/478983
- By:
- Publication type:
- Article
Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort.
- Published in:
- Prostate Cancer (20903111), 2014, p. 1, doi. 10.1155/2014/395078
- By:
- Publication type:
- Article
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.
- Published in:
- Prostate Cancer (20903111), 2014, p. 1, doi. 10.1155/2014/230812
- By:
- Publication type:
- Article
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 13, p. 2287, doi. 10.1002/cncr.35274
- By:
- Publication type:
- Article
Prostate‐specific antigen nadir and testosterone level at prostate‐specific antigen failure following radiation and androgen suppression therapy for unfavorable‐risk prostate cancer and the risk of all‐cause and prostate cancer–specific mortality
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2623, doi. 10.1002/cncr.33543
- By:
- Publication type:
- Article
Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.
- Published in:
- BJU International, 2012, v. 110, n. 11, p. 1690, doi. 10.1111/j.1464-410X.2012.11117.x
- By:
- Publication type:
- Article
Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade.
- Published in:
- BJU International, 2012, v. 110, n. 9, p. 1252, doi. 10.1111/j.1464-410X.2012.11118.x
- By:
- Publication type:
- Article
Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1787, doi. 10.1002/cncr.28609
- By:
- Publication type:
- Article
Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 18, p. 3280, doi. 10.1002/cncr.28202
- By:
- Publication type:
- Article
Comorbidity, Body Mass Index, and Age and the Risk of Nonprostate-Cancer-Specific Mortality After a Postradiation Prostate-Specific Antigen Recurrence.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 3, p. 610, doi. 10.1002/cncr.24818
- By:
- Publication type:
- Article
Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Influence of Body Mass Index on Prostate-Specific Antigen Failure After Androgen Suppression and Radiation Therapy for Localized Prostate Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 8, p. 1493, doi. 10.1002/cncr.22564
- By:
- Publication type:
- Article
Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 9, p. 2180, doi. 10.1002/cncr.22243
- By:
- Publication type:
- Article
The impact of a delay in initiating radiation therapy on prostate‐specific antigen outcome for patients with clinically localized prostate carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 2053
- By:
- Publication type:
- Article
Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 1, p. 56, doi. 10.1002/cncr.11053
- By:
- Publication type:
- Article
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 2, p. 281, doi. 10.1002/cncr.10657
- By:
- Publication type:
- Article
Accurate Gleason Grading of Prostatic Adenocarcinoma in Prostate Needle Biopsies by General Pathologists.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2003, v. 127, n. 8, p. 1007, doi. 10.5858/2003-127-1007-aggopa
- By:
- Publication type:
- Article